There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Avadel Pharmaceuticals plc ADR (AVDL) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.31, or -2.99%, to $10.07. The Avadel Pharmaceuticals plc ADR has recorded 8,084 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that Avadel Pharmaceuticals to Present at Upcoming Investor Conferences.
This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $10.38 and fluctuated between $10.72 as its day high and $10.34 as its day low. The current market capitalization of Avadel Pharmaceuticals plc ADR is $927.14M. A total of 0.75 million shares were traded on the day, compared to an average of 545.53K shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, AVDL has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 2 BUYs and 0 SELLs from insiders. Insiders purchased 33,000 shares during that period but sold 0.
In the most recent transaction, MCHUGH THOMAS S bought 2,000 shares of AVDL for 14.45 per share on Aug 14. After the transaction, the Chief Financial Officer now owns 78,500 company shares. In a previous transaction on Aug 11, McCamish Mark Anthony sold 28,975 shares at 14.93 per share. AVDL shares that Director owns now total 142,025.
Among the insiders who bought shares, Glass Geoffrey Michael acquired of 14,000 shares on Aug 10 at a per-share price of $13.40. This resulted in the Director holding 59,000 shares of AVDL after the transaction. In another insider transaction, Divis Gregory J bought 10,000 shares at $13.20 per share on Aug 10. Company shares held by the Chief Executive Officer now total 159,100.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for AVDL in the last 3 months, the mean price target is $19.89 with high estimates of $26.00 and low estimates of $17.00. In terms of 52-week highs and lows, AVDL has a high of $16.85 and a low of $5.64.
As of this writing, AVDL has an earnings estimate of -$0.37 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.42. The company reported an EPS of -$0.48 in the last quarter, which was -26.30% lower than expectations of -$0.38.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. AVDL’s latest balance sheet shows that the firm has $157.22M in Cash & Short Term Investments as of fiscal 2021. There were $145.00M in debt and $21.00M in liabilities at the time. Its Book Value Per Share was $1.51, while its Total Shareholder’s Equity was $78.24M.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AVDL is Buy with a score of 4.89.